Cargando…

The Impact of Inherited Thrombophilia Types and Low Molecular Weight Heparin Treatment on Pregnancy Complications in Women with Previous Adverse Outcome

PURPOSE: To assess the distribution of births and spontaneous abortions, first-trimester abortion (FTA) and mid-trimester abortion (MTA), in untreated (n=128) and low molecular weight heparin (LMWH) treated pregnancies (n=50) of the same women with inherited thrombophilias and adverse pregnancy outc...

Descripción completa

Detalles Bibliográficos
Autores principales: Aracic, Nada, Roje, Damir, Jakus, Ivana Alujevic, Bakotin, Marinela, Stefanovic, Vedran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960391/
https://www.ncbi.nlm.nih.gov/pubmed/27401656
http://dx.doi.org/10.3349/ymj.2016.57.5.1230
_version_ 1782444521495199744
author Aracic, Nada
Roje, Damir
Jakus, Ivana Alujevic
Bakotin, Marinela
Stefanovic, Vedran
author_facet Aracic, Nada
Roje, Damir
Jakus, Ivana Alujevic
Bakotin, Marinela
Stefanovic, Vedran
author_sort Aracic, Nada
collection PubMed
description PURPOSE: To assess the distribution of births and spontaneous abortions, first-trimester abortion (FTA) and mid-trimester abortion (MTA), in untreated (n=128) and low molecular weight heparin (LMWH) treated pregnancies (n=50) of the same women with inherited thrombophilias and adverse pregnancy outcome (APO) in previous pregnancies. We particularly investigated the impact of LMWH on reducing the pregnancy complications in two thrombophilia types, "Conventional" and "Novel". MATERIALS AND METHODS: 50 women with inherited thrombophilia (26 Conventional and 24 Novel) and APO in previous pregnancies were included in the study. Conventional group included factor V Leiden (FVL), prothrombin G20210A (PT) mutations and antithrombin (AT), protein S (PS), and protein C (PC) deficiency, while the Novel group included methylentetrahydrofolate-reductase (MTHFR), plasminogen activator inhibitor-1 (PAI-1), and angiotensin converting enzyme (ACE) polymorphism. APO was defined as one of the following: preterm birth (PTB), fetal growth restriction (FGR), preeclampsia (PE), intrauterine fetal death (IUFD), placental abruption (PA) and deep venous thrombosis (DVT). RESULTS: There was no difference in distribution of births and spontaneous abortions between Conventional and Novel thrombophilia in untreated pregnancies (χ(2)=2.7; p=0.100) and LMWH treated pregnancies (χ(2)=0.442; p=0.506). In untreaed pregnancies thrombophilia type did not have any impact on the frequency of FTA and MTA (χ(2)=0.14; p=0.711). In birth-ended pregnancies LMWH treatement reduced the incidence of IUFD (p=0.011) in Conventional and FGR, IUFD, and PTB in Novel thrombophilia group. CONCLUSION: The equal impact of two thrombophilia types on the pregnancy outcomes and a more favorable effect of LMWH therapy on pregnancy complications in Novel thrombophilia group point the need for Novel thrombophilias screening and the future studies on this issue should be recommended.
format Online
Article
Text
id pubmed-4960391
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Yonsei University College of Medicine
record_format MEDLINE/PubMed
spelling pubmed-49603912016-09-01 The Impact of Inherited Thrombophilia Types and Low Molecular Weight Heparin Treatment on Pregnancy Complications in Women with Previous Adverse Outcome Aracic, Nada Roje, Damir Jakus, Ivana Alujevic Bakotin, Marinela Stefanovic, Vedran Yonsei Med J Original Article PURPOSE: To assess the distribution of births and spontaneous abortions, first-trimester abortion (FTA) and mid-trimester abortion (MTA), in untreated (n=128) and low molecular weight heparin (LMWH) treated pregnancies (n=50) of the same women with inherited thrombophilias and adverse pregnancy outcome (APO) in previous pregnancies. We particularly investigated the impact of LMWH on reducing the pregnancy complications in two thrombophilia types, "Conventional" and "Novel". MATERIALS AND METHODS: 50 women with inherited thrombophilia (26 Conventional and 24 Novel) and APO in previous pregnancies were included in the study. Conventional group included factor V Leiden (FVL), prothrombin G20210A (PT) mutations and antithrombin (AT), protein S (PS), and protein C (PC) deficiency, while the Novel group included methylentetrahydrofolate-reductase (MTHFR), plasminogen activator inhibitor-1 (PAI-1), and angiotensin converting enzyme (ACE) polymorphism. APO was defined as one of the following: preterm birth (PTB), fetal growth restriction (FGR), preeclampsia (PE), intrauterine fetal death (IUFD), placental abruption (PA) and deep venous thrombosis (DVT). RESULTS: There was no difference in distribution of births and spontaneous abortions between Conventional and Novel thrombophilia in untreated pregnancies (χ(2)=2.7; p=0.100) and LMWH treated pregnancies (χ(2)=0.442; p=0.506). In untreaed pregnancies thrombophilia type did not have any impact on the frequency of FTA and MTA (χ(2)=0.14; p=0.711). In birth-ended pregnancies LMWH treatement reduced the incidence of IUFD (p=0.011) in Conventional and FGR, IUFD, and PTB in Novel thrombophilia group. CONCLUSION: The equal impact of two thrombophilia types on the pregnancy outcomes and a more favorable effect of LMWH therapy on pregnancy complications in Novel thrombophilia group point the need for Novel thrombophilias screening and the future studies on this issue should be recommended. Yonsei University College of Medicine 2016-09-01 2016-06-30 /pmc/articles/PMC4960391/ /pubmed/27401656 http://dx.doi.org/10.3349/ymj.2016.57.5.1230 Text en © Copyright: Yonsei University College of Medicine 2016 http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Aracic, Nada
Roje, Damir
Jakus, Ivana Alujevic
Bakotin, Marinela
Stefanovic, Vedran
The Impact of Inherited Thrombophilia Types and Low Molecular Weight Heparin Treatment on Pregnancy Complications in Women with Previous Adverse Outcome
title The Impact of Inherited Thrombophilia Types and Low Molecular Weight Heparin Treatment on Pregnancy Complications in Women with Previous Adverse Outcome
title_full The Impact of Inherited Thrombophilia Types and Low Molecular Weight Heparin Treatment on Pregnancy Complications in Women with Previous Adverse Outcome
title_fullStr The Impact of Inherited Thrombophilia Types and Low Molecular Weight Heparin Treatment on Pregnancy Complications in Women with Previous Adverse Outcome
title_full_unstemmed The Impact of Inherited Thrombophilia Types and Low Molecular Weight Heparin Treatment on Pregnancy Complications in Women with Previous Adverse Outcome
title_short The Impact of Inherited Thrombophilia Types and Low Molecular Weight Heparin Treatment on Pregnancy Complications in Women with Previous Adverse Outcome
title_sort impact of inherited thrombophilia types and low molecular weight heparin treatment on pregnancy complications in women with previous adverse outcome
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960391/
https://www.ncbi.nlm.nih.gov/pubmed/27401656
http://dx.doi.org/10.3349/ymj.2016.57.5.1230
work_keys_str_mv AT aracicnada theimpactofinheritedthrombophiliatypesandlowmolecularweightheparintreatmentonpregnancycomplicationsinwomenwithpreviousadverseoutcome
AT rojedamir theimpactofinheritedthrombophiliatypesandlowmolecularweightheparintreatmentonpregnancycomplicationsinwomenwithpreviousadverseoutcome
AT jakusivanaalujevic theimpactofinheritedthrombophiliatypesandlowmolecularweightheparintreatmentonpregnancycomplicationsinwomenwithpreviousadverseoutcome
AT bakotinmarinela theimpactofinheritedthrombophiliatypesandlowmolecularweightheparintreatmentonpregnancycomplicationsinwomenwithpreviousadverseoutcome
AT stefanovicvedran theimpactofinheritedthrombophiliatypesandlowmolecularweightheparintreatmentonpregnancycomplicationsinwomenwithpreviousadverseoutcome
AT aracicnada impactofinheritedthrombophiliatypesandlowmolecularweightheparintreatmentonpregnancycomplicationsinwomenwithpreviousadverseoutcome
AT rojedamir impactofinheritedthrombophiliatypesandlowmolecularweightheparintreatmentonpregnancycomplicationsinwomenwithpreviousadverseoutcome
AT jakusivanaalujevic impactofinheritedthrombophiliatypesandlowmolecularweightheparintreatmentonpregnancycomplicationsinwomenwithpreviousadverseoutcome
AT bakotinmarinela impactofinheritedthrombophiliatypesandlowmolecularweightheparintreatmentonpregnancycomplicationsinwomenwithpreviousadverseoutcome
AT stefanovicvedran impactofinheritedthrombophiliatypesandlowmolecularweightheparintreatmentonpregnancycomplicationsinwomenwithpreviousadverseoutcome